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ABSTRACT
Gene-recombinase technologies, such as Cre/loxP-
mediated DNA recombination, are important tools in
the study of gene function, but have potential side
effects due to damaging activity on DNA. Here we
show that DNA recombination by Cre instigates a
robust antiviral response in mammalian cells, inde-
pendent of legitimate loxP recombination. This is
due to the recruitment of the cytosolic DNA sensor
STING, concurrent with Cre-dependent DNA damage
and the accumulation of cytoplasmic DNA. Impor-
tantly, we establish a direct interplay between this
antiviral response and cell–cell interactions, indicat-
ing that low cell densities in vitro could be useful
to help mitigate these effects of Cre. Taking into ac-
count the wide range of interferon stimulated genes
that may be induced by the STING pathway, these
results have broad implications in fields such as
immunology, cancer biology, metabolism and stem
cell research. Further, this study sets a precedent
in the field of gene-engineering, possibly applicable
to other enzymatic-based genome editing technolo-
gies.
INTRODUCTION
The adoption of Cre/loxP-based DNA recombination has
dominated the field of site-specific gene recombination for
the past two decades. This system relies on the bacterio-
phage P1 Cre recombinase, which promotes the catalytic ex-
cision of DNA segments flanked by two palindromic 34-bp
loxP sites (1,2). The 34-bp loxP site consists of two 13-bp
inverted motifs, and a central 8-bp spacer. Critically, alter-
ation of the central eight nucleotide spacer directly impacts
the efficiency of Cre recombination and truncation of this
central motif leads to the formation of single stranded nicks
in DNA (1).
It became evident more than 15 years ago that sites
strongly resembling the 34-bp loxP site (referred to as
pseudo-loxP sites) exist in the human and mouse genomes,
and can be recombined by Cre (3). Such sites are relatively
frequent, with as many as 250 and 300 pseudo-loxP sites
predicted in mouse and human genomes, respectively (4).
Whether or not Cre activity on such pseudo-loxP sites re-
sults in single stranded DNA nicks is ill-defined, but Cre
overexpression directly alters the integrity of chromosomes,
with increased chromatid breaks, dicentric chromosomes,
sister chromatid exchange and aberrant gaps/fragments
previously reported (5,6). Such activities are due to the en-
donuclease activity of Cre on DNA (6), and result in de-
creased cell proliferation, increased apoptosis and cell accu-
mulation in G2/M phase (4–7). It is noteworthy that these
genotoxic effects of Cre are similar to those observed with
the topoisomerase I ligase inhibitor camptothecin (5).
The innate immune system is one of the first lines of de-
fense against pathogens such as viruses. It is based on the
detection of pathogen associated molecular patterns by spe-
cific sensors, which activate a broad response to fight the
infection rapidly and recruit the adaptive immune system
for further protection. Type I interferons (IFNs) are cy-
tokines that are essential effectors of innate immunity, and
their secretion by a few infected cells instigates a global
antiviral effect throughout the infected host by inducing
more than 2000 genes (8). STING is an intracellular adap-
tor molecule associated with the endoplasmic reticulum
membrane of many immune cells from haematopoietic ori-
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gin, together with various epithelial cell types (9). In 2008,
STING was discovered to play a critical role in detecting
pathogen-derived DNA in the cytoplasm (10). Upon trans-
fection of foreign DNA into the cytoplasm, STING is phos-
phorylated to initiate the transcriptional activation of an-
tiviral genes (including type-I IFN) through the transcrip-
tion factor IFN regulatory factor 3 (11). In 2013, cyclic-
GMP-AMP (cGAMP) synthase (cGAS) was found to op-
erate upstream of STING to directly bind double stranded
DNA in the cytoplasm and generate the second messenger
cGAMP, which activates STING (12). Recent evidence sug-
gests that DNA damage caused by DNA damaging agents
such as camptothecin results in the activation of the cGAS-
STING pathway (13). Nonetheless, to our knowledge, the
impact of Cre-mediated DNA damage on the innate im-
mune system has not previously been assessed.
Here, while originally aiming at defining the regulatory
roles of microRNAs (miRNAs) during viral infections, we
observed that Cre activation resulted in the strong induc-
tion of an antiviral response, independent of loxP target-
ing. We demonstrate that Cre-mediated DNA recombina-
tion can activate the cytosolic STING pathway, leading to
the induction of type-I IFN in mammalian cells.
MATERIALS AND METHODS
Ethics statement
The use of animals and experimental procedures were ap-
proved by the Monash Medical Centre Ethics Committee
under references MMCA/2008/26/BC, MMCA2012/75BC,
MMCA2011/25 and MMCA2012/13.
Animals
C57BL/6 × 129 Dicer1flox/flox(referred to as Dicer1f/f) mice
bred to C57BL/6 × 129 R26CreERT mice (14) express-
ing the Cre-ERT fusion protein (15) (composed of a mu-
tated human estrogen receptor ligand binding domain
that selectively binds hydroxy-tamoxifen (OHT), and is se-
questered in the cytoplasm in the absence of OHT) from
the ROSA26 locus, were previously reported (16). Dicer1f/wt
× Cre/ESR1+, Dicer1f/f × Cre/ESR1+, Dicer1wt/wt ×
Cre/ESR1+ and Dicer1wt/wt × Cre/ESR1− mouse embry-
onic fibroblasts (MEFs) from day 12–14 embryos were
immortalized following transfection of pSG5-SV40-LT-
Ag and six successive 1/10 passages. Two different cell
lines were generated from two different embryos for both
Dicer1f/f × Cre/ESR1+ and Dicer1wt/wt × Cre/ESR1+,
and yielded similar results. Primary Sting+/+ and Sting−/−
MEFs were used at early passages with no immortalization.
For bone marrow derived macrophages (BMDMs), bone
marrow was isolated from the femurs of the mice and dif-
ferentiated in 20% L929-cell-conditioned medium for 6 days
at 37◦C in a 5% CO2 atmosphere. For in vivo tamoxifen in-
jection, 10-12-week-old mice were injected with tamoxifen
(Sigma) (1 mg) diluted in peanut oil by i.p. injection (100
l) for five consecutive days (days 1–5). Blood mononu-
clear cells were purified from whole blood on day 12 after
euthanasia of the animals with CO2, using adapted Ficoll-
Paque plus purification (17) and RNA was purified using
the mirVana miRNA isolation kit (Life Technologies). An-
imal studies were not blinded.
Cell culture
BMDMs, MEFs, Vero cells (ATCC R© CCL81TM), HEK
293T cells (referred to as HEK throughout the stud-
ies) and LentiXTM 293T cells (Clontech) were grown in
Dulbecco’s modified Eagle’s medium (Life Technolo-
gies) supplemented with 10% sterile fetal bovine serum
(Life Technologies) and 1× antibiotic/antimycotic (Life
Technologies) (referred to as complete DMEM). Primary
Sting+/+ and Sting−/− MEFs were cultivated in Dul-
becco’s modified Eagle’s medium supplemented with 10%
sterile fetal bovine serum, P/S, -mercaptoethanol and
non-essential amino acids. Human A549 cells (ATCC R©
CCL-185TM) were grown in Advanced RPMI medium
(Life Technologies) supplemented with 1% sterile fetal
bovine serum. HEK Sting and HEK Sting CX43/45DKO
cells stably expressing the murine Sting fused to an N-
terminal mCherry-tag were previously described (18).
MEFs were genotyped regularly for Dicer1 floxed locus




OHT treatment of MEFs was carried out as previously
described (16), using 500 nM OHT (Sigma) for 16–24 h,
and rinsed the next day with fresh medium. For BMDMs,
bone-marrow cells were washed on day 3 of differentiation,
with fresh medium supplemented with 20% L929-cell-
conditioned medium and 500 nM OHT. The cells were
rinsed and collected on day 5, and plated in 24-well plates
in 20% L929-cell-conditioned medium, prior to lysis for
western blot and RNA analyses at day 6. HEK Sting
cells were stimulated for 4 hrs with 15 l/ml of DMXAA
resuspended in DMSO (Sigma).
Western blotting
MEFs were plated at different densities to reach full con-
fluency at 24, 48, 72 or 96 h post OHT treatment (with the
exception of Figure 5E). Lysates were separated at 80 V on
10% acrylamide gel for 2 h. Transfer was carried out at 20 V
for 1.5 h using Bolt Mini Blot Modules (Life Technologies)
to Immobilon-FL (Millipore) membranes. After blocking
in Odyssey blocking buffer (LI-COR) for 30 min, the mem-
branes were incubated overnight with 1:1000 mouse mon-
oclonal anti-Viperin (MaP.VIP | #MABF106) (Millipore),
rabbit anti-mouse p56 (gift from Ganes Sen, Cleveland
Clinic, Cleveland, OH, USA), mouse monoclonal anti--
tubulin (TU-06 | ab7792) (Abcam) or monoclonal rabbit
anti-STING (D2P2F | #13647) (Cell Signaling). Conju-
gated secondary with Alexa Fluor R© 680 dye (Life Technolo-
gies) or IRdye800 (Rockland) was subsequently used to im-
age the proteins at 700 or 800 nm with an Odyssey scanner
(LI-COR).
Semliki forest virus (SFV) infection
A total of 120 000 MEFs were seeded 3 or 4 days after OHT
treatment in 24-well plates, and left to adhere for several
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hours, prior to infection with semliki forest virus (SFV) in
complete DMEM (MOI 2––as determined by plaque form-
ing units in Vero cells) (each condition was carried out in
biological triplicate). The cells were rinsed 2 h after infec-
tion with fresh medium complemented with 2.5% FCS, and
further incubated for 22 h. Virus-containing supernatants
were collected at 24 h and series-diluted (10-fold dilutions)
on 80% confluent Vero cells in 96-well plates (in 5% FCS
complete DMEM). After 48 h, surviving Vero cells were
fixed with 10% formalin and stained with 0.1% crystal vi-
olet (w/v) in 20% ethanol, before thorough H2O washes.
Statistical analyses
Statistical analyses were carried out using Prism 6 (Graph-
Pad Software Inc.). Two-tailed unpaired non-parametric
Mann–Whitney U tests or two-tailed unpaired t-tests with
Welch’s correction (to compare pairs of conditions), one-
way ANOVA with Tukey’s multiple comparisons tests (to
compare more than two conditions) or two-way ANOVA
with Sidak’s multiple comparisons tests (to compare groups
of conditions) are shown when appropriate. Symbols used:
*P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001, ****P ≤ 0.0001.
RESULTS
Cre-ERT activation induces a strong antiviral response in
mouse embryonic fibroblasts (MEFs) and animals
We have recently reported an important role for microR-
NAs in the regulation of inflammation through the con-
trol of nuclear factor kappa B (NF-B) signaling in MEFs
(19). To define the impact of miRNAs on viral infections
following global miRNA depletion, we infected immor-
talized MEFs with SFV, 4 days after OHT-induced Cre-
ERT-mediated deletion of Dicer1 (16). We chose this dura-
tion based on our previous observation that miRNAs are
decreased by more than 50–60% at that point in time in
this model (16,20). Cre-ERT-mediated deletion of Dicer1
resulted in a marked decrease in viral titers (Figure 1A),
with concurrent induction of the key antiviral proteins
p56 (21) (encoded by Ifit1) and Viperin (22) (encoded by
Rsad2) (Figure 1B). Unexpectedly, this effect was observed
in both Dicer1f/f × Cre/ESR1+ and heterozygous Dicer1f/wt
× Cre/ESR1+ cells. Accordingly, both Ifit1 and Rsad2 were
induced in vivo in peripheral blood mononuclear cells from
Dicer1f/f × Cre/ESR1+ and Dicer1f/wt × Cre/ESR1+ an-
imals treated with tamoxifen, 7 days after the last injec-
tion (Figure 1C). Because in Dicer1f/wt × Cre/ESR1+cells
the levels of most miRNAs were not changed (Gantier,
M., unpublished observation), we investigated the poten-
tial contribution of the Cre-ERT system to this antiviral
activity, independent of Dicer1 deletion and miRNA bio-
genesis. Remarkably, transient Cre-ERT activation alone re-
sulted in the induction of p56 and Viperin in Dicer1wt/wt
× Cre/ESR1+ MEFs, while being sufficiently robust to
strongly inhibit SFV replication, independent of the OHT
treatment itself (Figure 1D and E).
Dose-dependent activation of type-I IFN gene signatures in
MEFs by Cre-ERT
Having shown a strong antiviral effect of Cre-ERT acti-
vation in the absence of loxP site recombination, we de-
cided to investigate the potential mechanism at play. Spec-
ulating the recruitment of type-I IFNs, genome-wide mi-
croarray analyses of three different Cre/ESR1+ MEF cell
lines was carried out (Dicer1f/f × Cre/ESR1+, Dicer1f/wt
× Cre/ESR1+ and Dicer1wt/wt × Cre/ESR1+) (Figure 2A).
This analysis confirmed that OHT stimulation of Cre-ERT,
and not the recombination of targeted loxP sites, resulted
in the induction of a classical type I IFN-stimulated gene
(ISG) signature––including the antiviral genes Rsad2, Ifit1,
Ifih1, Ddx58 and Ifnb1 (Figure 2A). Of note, this induc-
tion was delayed and exhibited only 48–72 h post ini-
tial OHT treatment (Figure 2B and Supplementary Figure
S1A). In addition, the expression of many antiviral genes
was basally higher in all Cre/ESR1+ lines compared to wild-
type MEFs, indicative of leaky Cre-ERT activity, consis-
tent with a previous report (5)(Figure 2A and B). We also
noted significant variations in the basal levels of certain
ISGs between different Cre/ESR1+ lines, with the exam-
ple of Rsad2 which was >20-fold higher in Dicer1wt/wt ×
Cre/ESR1+ compared to Dicer1f/wt × Cre/ESR1+, possi-
bly explaining the earlier/higher induction of Viperin lev-
els seen in Figure 1 (Figure 2B, Supplementary Figure S1A
and not shown). Given that Cre-ERT was found to lack off-
target effects with lower OHT doses, we next assessed the
induction of p56 and Viperin with different doses of OHT.
Although clearly dose-dependent, induction of the antiviral
proteins was still apparent at 10 nM OHT, a dose previously
thought to avoid Cre off-target effects (5) (Figure 2C).
Cre induces antiviral genes in mouse macrophages and human
epithelial cells
To define whether the antiviral signature observed was re-
stricted to MEFs, primary BMDMs from Dicer1f/wt ×
Cre/ESR1+, Dicer1wt/wt × Cre/ESR1+ and the control
Dicer1wt/wt × Cre/ESR1− mice were treated with OHT.
Similar to MEFs, induction of p56 and Viperin by OHT
in BMDMs was also Cre-ERT dependent (Figure 3A and
Supplementary Figure S1B). Expression analysis of eight
known ISGs in OHT-treated Dicer1wt/wt × Cre/ESR1+
BMDMs confirmed the hallmark of a type-I IFN response
in these cells (Figure 3B). Furthermore, stable overexpres-
sion of Cre in human A549 cells was also able to induce
ISGs, confirming that these observations were not restricted
to the murine Cre-ERT model (Figure 3C). Critically, the
Cre-mediated ISG induction relied on the endonuclease ac-
tivity of Cre on DNA since stable overexpression of an enzy-
matic point mutant (Cre-R173K (5)) was not able to induce
IFIT2, while expressing as much Cre-R173K mRNA as the
native gene (Figure 3D). Collectively, these results demon-
strate that the activation of a type-I IFN antiviral response
by Cre, in both mouse and human cells, depends on the cat-
alytic activity of Cre.
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Figure 1. Cre-ERT-mediated activation of an antiviral response. (A) MEFs treated for 24 h with OHT were expanded for 3 days, prior to 24 h infection in
biological triplicate with SFV (MOI 2). Viral titers were assayed with log10 fold dilutions on confluent Vero cells as shown. NI: not infected (uninfected
cells were stained with crystal violet). (B) Time course showing the activity of 24 h OHT treatment of Dicer1f/f x Cre/ESR1+ and Dicer1f/wt Cre/ESR1
+ MEFs on the levels of Viperin and p56. (A, B) Data shown are representative of a minimum of two independent experiments. NT: non-treated. (C)
Peripheral blood mononuclear cells from mice injected with oil or tamoxifen for five consecutive days, and culled on day 12, were analyzed by RT-qPCR
for ISG expression (each point represents one mouse; mean ± s.e.m. and unpaired Mann-Whitney U tests are shown). Data shown relative to the mean
ISG/18S expression of the oil control samples. nd: non-detected in three out of four mice. (D) MEFs treated for 24 h with OHT were expanded for two
days, prior to 24 h infection in biological triplicate with SFV (MOI 2) and viral titers on confluent Vero cells as in (A). (E) Time course showing the activity
of 24 h OHT treatment of Dicer1wt/wt x Cre/ESR1+ and Cre/ESR1− MEFs on the levels of Viperin and p56. (C-E) Data shown are representative of three
independent experiments or mice.
Cre-ERT activation induces DNA damage and accumulation
of cytoplasmic DNA products
Given the previous reports that Cre overexpression pro-
motes DNA damage, leading to decreased cell prolifer-
ation (4–6), we next assessed DNA damage following
OHT treatment of Cre/ESR1+MEFs. In accordance with
these previous reports, the number of  -H2A.X-positive
cells was significantly increased after OHT treatment of
Cre/ESR1+ cells (Figure 4A and B). Critically, part of
the  -H2A.X staining seen in OHT-treated Cre/ESR1+
cells was often present in foci outside of the nucleus (Fig-
ure 4A). Such cytoplasmic localization was recently shown
for histone H3 upon DNA damage with the carcinogen
7,12-dimethylbenz[a]anthracene (DMBA), concurrent with
leakage of DNA products to the cytoplasm (13). Speculat-
ing that the DNA damage promoted by Cre could also lead
to such cytoplasmic DNA leakage, we next analyzed OHT-
treated Cre/ESR1+ cells for DNA staining using a pan anti-
DNA antibody. This analysis revealed increased levels of cy-
toplasmic DNA foci upon OHT stimulation of Cre/ESR1+
cells, but not the control Cre/ESR1− cells, clearly pointing
to an accumulation of cytoplasmic DNA upon Cre activa-
tion (Figure 4C and D). This led us to speculate that the
type-I IFN response observed with Cre was instigated by
the activation of a cytoplasmic DNA sensor.
STING-dependent activation of antiviral genes upon Cre-
ERT activation or Cre overexpression
Induction of ISG responses to several DNA-damaging
agents was recently shown to result in cytoplasmic DNA
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Figure 2. Cre-ERT-dependent activation of type-I IFN gene signatures. (A) Microarray analysis of MEFs (48 h post-initial OHT treatment for Dicerwt/wt
× Cre/ESR1+ and Cre/ESR1− cells and 96 h for Dicer f/wt × Cre/ESR1+and Dicer f/f cells), restricted to 23 ISGs. NT: non-treated. (B) RT-qPCR analysis
of ISGs in MEFs after 24 h OHT treatment. Data are shown relative to non-treated Cre/ESR1− cells (data are presented as mean of three independent
experiments in biological duplicate ± s.e.m.). (C) Dose-response study of varying concentrations of OHT on MEFs, on the levels of Viperin and p56, 72 h
after stimulation. (B and C) Data shown are representative of three independent experiments.
leakage, sensed by the cytosolic cGAS-STING innate im-
mune pathway (13,23). We posited that a similar mechanism
could be at play with Cre. Accordingly, we examined the in-
volvement of the cGAS-STING pathway in Cre-dependent
ISG induction. Small interfering RNA (siRNA)-mediated
knockdown of STING or cGAS in Dicer1f/f × Cre/ESR1+
and Dicer1wt/wt × Cre/ESR1+ MEFs, before OHT-driven
Cre-ERT activation, strongly inhibited p56 and Viperin in-
duction in both cell types (Figure 5A and B; Supplemen-
tary Figure S2A and B). To confirm these results, we next
assessed the requirement for STING in the induction of
antiviral Rsad2 and Ifit1 genes upon stable expression of
Cre in primary MEFs from wild-type and Sting-deficient
mice. Similarly to what we observed upon downregulation
of Sting in Cre/ESR1+ MEFs, genetic ablation of STING
abolished the induction of ISGs upon stable Cre overex-
pression in primary MEFs (Figure 5C). Collectively, these
results establish the requirement for STING in inducing an-
tiviral genes by Cre overexpression or Cre-ERT activation.
Cell-density-dependent amplification of Cre-mediated ISG
induction
cGAMP (2′-5′), the product of cGAS and the effector of the
cGAS-STING pathway, can be transmitted between cells
through connexins that form gap junctions to confer by-
stander immunity in adjacent cells (18). In line with our
microarray analysis (Figure 2) that indicated a basal en-
gagement of cGAS in Cre/ESR1+MEFs, we performed co-
culture studies of Dicer1f/f × Cre/ESR1+ or Dicer1wt/wt ×
Cre/ESR1+ MEFs with HEK cells expressing the murine
Sting and an IFN--Luciferase reporter (18). In these ex-
periments, we observed significantly upregulated IFN- ex-
pression (see siNC5 condition; Figure 5D and Supplemen-
tary Figure S2C). This effect was not seen in co-cultures
with WT HEK cells, which are not naturally responsive
to cGAMP (Figure 5D) (18). This effect was also absent
in co-cultures with HEK cells double-deficient in connexin
43 (CX43) and 45 (CX45), but which expressed Sting (18);
nor was it seen when downregulation of cGAS was carried
out in Cre/ESR1+ MEFs prior to co-culture (Figure 5D
and Supplementary Figure S2C). Collectively, these results
support the existence of a basal and functional cGAMP-
like activity in Cre/ESR1+ MEFs, since cGAS, CX43/45
and STING are necessary for activation of a bystander ef-
fect in HEK cells, initiated from Cre/ESR1+ cells. However,
this cGAMP-like activity was not significantly induced in
Cre/ESR1+ MEFs treated with OHT using this co-culture
system, possibly relating to high basal cGAMP-like ac-
tivities (not shown). Nevertheless, in line with an ampli-
fication of STING engagement driven by Cre-ERT acti-
vation, OHT-dependent induction of p56 and Viperin in
Cre/ESR1+ MEFs was directly dependent on cell:cell in-
teractions, and was virtually absent in cells grown at low
density (Figure 5E and Supplementary Figure S2D).
DISCUSSION
The diversity of inducible and/or tissue-specific Cre-
expressing transgenic lines created to date suggest that the
Cre/loxP-based system is likely to remain an essential and
highly efficacious technology for the foreseeable future, de-
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Figure 3. Cre catalytic activity on DNA induces antiviral genes in human
and mouse cells. (A) Viperin and p56 levels in BMDMs from Dicer1f/wt
× Cre/ESR1+ and Dicer1wt/wt × Cre/ESR1+ animals treated with OHT.
(B) BMDMs from Dicer1wt/wt × Cre/ESR1+mice were analyzed for ex-
pression of the indicated ISGs by RT-qPCR analysis (data are presented
as mean of three independent experiments in biological duplicate ± s.e.m.,
with unpaired Mann–Whitney U tests to the non-treated condition). (A
and B) Data shown are representative of three independent experiments
or mice. (C) Human A549 cells stably expressing Cre or Citrine (control)
were analyzed by RT-qPCR for ISG expression. Data presented are from
five independent cell lines ± s.e.m., reported relative to the mean ISG/18S
expression of the Citrine samples, with unpaired Mann–Whitney U tests
to the control condition. (D) Left panel: human A549 cells stably express-
ing Cre, Cre-R173K or Citrine (control) were analyzed by RT-qPCR for
IFIT2/18S expression, reported relative to the Citrine condition. Right
panel: RT-qPCR of Cre/18S expression reported relative to the Cre condi-
tion (nd: not detected). Data presented are from two independent experi-
ments, with five biological replicates per experiment ± s.e.m., with one-way
ANOVA to the Citrine condition.
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Figure 4. Cre-ERT activation increases DNA damage and cytoplasmic
DNA. (A) Immunofluorescence of  -H2A.X staining (red) of Dicer1wt/wt
× Cre/ESR1+ MEFs after 72 h OHT (red arrows point to a cytoplas-
mic bright foci) or camptothecin treatment (5 M for 2 h––positive con-
trol), and (B) quantification of cells showing bright foci per field (each
point represents one field; data are averaged from two experiments for
Cre/ESR1+ MEFs ± s.e.m. with one-way ANOVA to Cre/ESR1+ NT con-
dition shown). (C) Immunofluorescence of anti-DNA staining in MEFs
after 72 h OHT treatment (red arrows point to cytoplasmic foci) and (D)
quantification of cells showing bright cytoplasmic foci (each point repre-
sents one field; data are averaged from two independent experiments ±
s.e.m. with one-way ANOVA to NT conditions shown). NT: non-treated.
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Figure 5. Cre-mediated DNA damage activates the STING pathway. (A) Dicer1wt/wt × Cre/ESR1+MEFs were transfected with 10 nM of the indicated
siRNAs overnight, prior to 24 h OHT stimulation. Viperin and p56 levels were analyzed 72 h after stimulation (siNC5 is a non-targeting siRNA and siSt-
ing#1Mut is a control siSting#1 sequence mutated to prevent Ago2-mediated mRNA cleavage; Mock is transfection reagent only). Blots are representative
of three independent experiments. (B) siRNA-targeted genes in Dicer1wt/wt × Cre/ESR1+MEFs were measured 48 h after transfection of 10 nM of the
indicated siRNAs (data are presented as mean of three independent experiments in biological duplicate ± s.e.m. with two-way ANOVA to siSting#1Mut
condition). (C) Primary Sting+/+ or Sting−/− MEFs stably expressing Cre or Citrine (Control) were analyzed by RT-qPCR for ISG expression. In each
experiment, ISG/18S levels in Cre-expressing cells were normalized to ISG/18S levels in Citrine-expressing cells, for each genotype. Data presented are
averaged from three independent experiments ± s.e.m., with unpaired t-tests with Welch’s correction. (D) HEK WT, Sting and Sting CX43/45DKO cells
expressing an IFN--Luciferase reporter were cultured alone (NT and DMXAA conditions), or co-cultured 48 h with Dicer1wt/wt × Cre/ESR1+MEFs
pre-treated for 24 h with 10 nM siNC5 or sicGAS#2. DMXAA was used as a known agonist of mouse STING (38). IFN--Luciferase expression was
reported relative to the NT condition for each cell line (data presented are averaged from two independent experiments in biological triplicate ± s.e.m. with
one-way ANOVA to the NT condition shown). (E) 12 000 Dicer1f/f × Cre/ESR1+ MEFs were seeded in 24, 12 or 6-well plates, prior to 24 h treatment
with OHT. Viperin and p56 levels were analyzed 72 h after stimulation, the time by which the cells reached high (24-well), intermediate (12-well) or low
(6-well) density. Blots are representative of three independent experiments.
spite the advent of new gene-editing technologies such as
TALENs and CRISPR-Cas9. Importantly, the non-specific
effects of Cre are well documented in the literature, in
vitro (in cell types including: HEK 293 cells, HeLa cells,
NIH3T3 cells, COS-7 cells, CV-1 cells, U2OS cells and pri-
mary MEFs (5–7)), but also in vivo (for example in the stria-
tum or hippocampus (7), in spermatids (24), in hematopoi-
etic cells (25), in the heart (26), in c-Myc-transformed B cell
lymphomas (27) and the central nervous system (28)). Con-
sequently, the use of Cre-only controls or self-deleting Cre
has been recommended in several instance to help mitigate
the non-specific effects of Cre (5–7,27–29).
In the present work we aimed to define the overall contri-
bution of miRNAs to the modulation of antiviral responses.
Unexpectedly, we noted that partial deletion of Dicer1, in
Dicer1f/wt × Cre/ESR1+ MEFs, resulted in a similar antivi-
ral response to that observed upon complete Dicer1 dele-
tion (Figure 1). Given prior reports of a non-specific ac-
tivity of Cre-ERT activation in MEFs, we investigated the
potential contribution of Cre in the antiviral effects ob-
served. Relying on (i) the downregulation of Sting expres-
sion in Cre/ESR1+ MEFs through two different siRNAs,
and (ii) Sting-deficient primary MEFs overexpressing Cre,
we establish that Cre-ERT activation and Cre overexpres-
sion activate a type-I IFN response, through recruitment of
cytosolic STING.
Given both the prior demonstrations that Cre overex-
pression or Cre-ERT activation promote DNA damage (4–
6), as well as our own observations (Figure 4), we pro-
pose that Cre-dependent STING activation is mediated
by DNA products leaked to the cytoplasm. This is con-
sistent with our observation of cytoplasmic DNA stain-
ing upon Cre-ERT activation, and two independent stud-
ies establishing STING activation upon DNA damage by
camptothecin and several other DNA-damaging agents
(DMBA, cisplatin, etoposide and  -irradiation) (13,23).
Importantly, deficiency of the DNaseIII TREX1, involved
in the degradation of cytoplasmic DNA, was found to exac-
erbate the accumulation of cytoplasmic DNA and histone
H3 upon induction of DNA damage, while leading to an
increased STING-mediated ISG induction (13). These find-
ings clearly point to a critical role for cytoplasmic DNA of
endogenous origin leaked from the nucleus, in STING acti-
vation by DNA damage. Although mechanistic differences
between Cre-mediated DNA damage and that of agents
such as camptothecin are likely, the kinetics of ISG in-
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duction upon camptothecin or DMBA treatment is in line
with our observations of Cre-ERT activation by OHT, seen
around 48–72 h (13). This is in agreement with a build up
of DNA damage (seen with increased  -H2A.X staining at
24 h and beyond), and an amplification of the response be-
tween cells.
Critically, we found that cell density was essential in the
detection of an ISG response in OHT-treated Cre/ESR1+
MEFs (Figure 5). Given that Cre-mediated DNA damage
is unlikely to be dependent on cell confluency, this find-
ing supports the concept of an amplification of the ISG
response between cells. Furthermore, the requirement for
cell:cell interactions suggest that such amplification pre-
dominantly relies on an IFN-independent mediator. Our
observation that Cre-ERT-driven ISG induction is entirely
blunted by two different siRNAs that downregulate cGas
expression in Cre/ESR1+ MEFs supports the concept that
cGAS is involved in detecting cytoplasmic DNA products
generated by Cre. cGAS downregulation was also found
to decrease ISG induction by camptothecin and DMBA in
Trex1-deficient MEFs (13). Given that cGAMP, the prod-
uct of cGAS, is diffusible between cells that form gap junc-
tions, we reasoned that it was most likely involved in the
amplification of the ISG response between confluent cells.
We showed that Dicer1wt/wt × Cre/ESR1+ and Dicer1fl/fl
× Cre/ESR1+ MEFs exhibited basal levels of cGAMP-
like activity, dependent on cGAS expression in MEFs, and
CX43/45/STING expression in adjacent recipient cells.
This basal cGAMP-like activity was presumably involved
in Viperin/p56 induction seen at 96 h in highly confluent,
non-stimulated Dicer1wt/wt × Cre/ESR1+ and Dicer1fl/fl ×
Cre/ESR1+MEFs (Figure 1). Nonetheless, we were unable
to detect an increased cGAMP-like activity upon OHT
treatment of Cre/ESR1+ MEFs, relying on the same bio-
logical assay. Importantly, treatment of wild-type immor-
talized MEFs with camptothecin, only led to a ∼1.5–2-fold
increase of cGAMP-like activity (Pépin et al., in prepara-
tion). Given that Cre-ERT-mediated DNA damage is not
expected to be as strong as that of camptothecin, as it does
not equally affect every cell, it is likely that the sensitivity of
our cGAMP biological assay was not great enough to dif-
ferentiate increases of cGAMP activity from basal cGAMP
levels in a small proportion of cells. However, it is note-
worthy that the activity of STING can be modulated inde-
pendently of cGAS/cGAMP by other DNA-binding pro-
teins (9), or by membrane fusions (30). As such, we can-
not rule out that the activation of STING following Cre-
ERT activation partially relies on another DNA sensor than
cGAS, whose function could be controlled by cGAS and
basal cGAMP levels (31), but not mediated by cGAMP.
We found that the catalytic activity of Cre was essential
for its ability to induce an IFN-response in human cells.
Similar to its effects on DNA damage and cell proliferation
(4,6), this indicates that the DNA cleavage by Cre is required
for STING activation. Given that this activity of Cre was
independent of loxP sites, it is reasonable to assume that it
pertains to its activity on pseudo-loxP sites (27). Whether
or not Cre activity on genomic pseudo-loxP sites results in
single stranded DNA nicks and cytoplasmic DNA products
remains to be defined, but it would be consistent with its re-
ported nickase activity when binding to ‘mutated’ loxP sites
(1).
In summary, we have shown here that DNA damage re-
sulting from legitimate and illegitimate Cre enzymatic ac-
tivity can result in the activation of the STING antiviral
pathway. Given the vast array of genes regulated by the
IFN pathway (∼2000 genes (8)), and the wide range of
their auto- and paracrine functions, these findings demon-
strate the need for caution in the interpretation of data
from Cre/loxP-based studies that do not include appropri-
ate Cre-only controls (reviewed in (28)). Beyond the previ-
ously known effects of Cre on DNA damage, the additional
involvement of IFNs by Cre recombination discovered in
this work has functional consequences for many pathways
and tissues, through modulation of several key transcrip-
tion factors/modulators, including the IRF/STAT, SMAD,
KLF, HDAC and ETS families (32). As such, in addition to
having implications for studies of the immune system, the
IFN induction reported here has broad consequences for
many other fields such as cancer biology, metabolism, stem
cell research and neurology (9,33–35).
Although the STING pathway described in this work
may not be functional in every cell type, our studies indicate
that in vitro experiments relying on Cre/ESR1+ cell mod-
els should be performed at low densities, to limit the risk of
amplification and minimize the potential bias introduced by
the IFN pathway. In addition, we propose that measuring
the expression of select ISGs could be useful, in order to rule
out potential off-target effects of Cre technologies related
to other aspects of DNA damage, with specific relevance to
hematopoietic tissues where STING is functional. Finally,
our findings suggest that gene-editing technologies relying
on DNA nickases (such as Cas9 nickase mutant (36)) may
also be under the innate immune radar, and that similar cau-
tion and appropriate controls should be used in experiments
employing these technologies. Conversely, novel gene edit-
ing technologies that do not rely on DNA cleavage, such as
CRISPR/Cas9 cytidine deaminase (37), should help avoid
innate immune recognition by the pathways described here.
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